C21 Investments Inc. (CWLXF): Share Repurchases

Annual figures by period end, from SEC filings.

$103.0K
Year ended 2026-03-31
$276.7K2024-01-31: $02025-03-31: $276.7K2026-03-31: $103.0K$103.0K
2024-01-31 Share Repurchases (USD) 2026-03-31
Period endedShare RepurchasesChange YoYSource filing
2026-03-31$103.0K-62.8%2026-06-12, From 2025-04-01
2025-03-31$276.7Kn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$0n/a2025-06-23, From 2023-02-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$103.0K-62.8%
Mannatech Inc (MTEX)2024-12-31$0-100.0%
Niagen Bioscience, Inc. (NAGE)2025-12-31$251.0Kn/a
Natural Alternatives International Inc (NAII)2025-06-30$178.0K-19.5%
Cronos Group Inc. (CRON)2025-12-31$9.74Mn/a
biote Corp. (BTMD)2025-12-31$3.37M-39.9%
USANA Health Sciences Inc (USNA)2026-01-03$27.51M+191.3%

Compare CWLXF, MTEX, NAGE, NAII side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗